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ABSTRACT 
Purpose: Acute kidney injury (AKI) − an abrupt loss of kidney function − is a common 
and serious complication after a surgery which is associated with a high incidence of 
morbidity and mortality. The majority of existing perioperative AKI risk score prediction 
models are limited in their generalizability and do not fully utilize the physiological 
intraoperative time-series data. Thus, there is a need for intelligent, accurate, and 
robust systems, able to leverage information from large-scale data to predict patient’s 
risk of developing postoperative AKI.  
Materials and Methods: A retrospective single-center cohort of 2,911 adult patients 
(age ≥ 18) who underwent surgery at the University of Florida Health from 2000 to 2010 
and had a length of stay > 24 hours, has been used for this study. We study the 
incorporation of intraoperative time-series features to the preoperative prediction risk 
score can enrich the performance of the predictive models in classifying patients who 
will develop postoperative AKI. We used machine learning and statistical analysis 
techniques to develop perioperative models to predict the risk of acute kidney injury 
(postoperative risk during the first 3 days, 7 days, and until the discharge day) before 
and after the surgery. In particular, we examined the improvement in risk prediction by 
incorporating intraoperative physiologic time series data, such as, mean arterial blood 
pressure (MAP), systolic blood pressure, diastolic blood pressure, minimum alveolar 
concentration (MAC), and heart rate (HR), etc. For an individual patient, the 
preoperative model produces a probabilistic AKI risk score, which will be enriched by 
integrating intraoperative statistical features through a machine learning stacking 
approach inside a random forest classifier. Using the Yoden’s index based cut-off 
optimization, the model stratifies patients into low and high risk categories. We 
compared the performance of our model based on the area under the receiver operating 
characteristics curve (AUROC), accuracy and net reclassification improvement (NRI) 
metrics. 
Results: The prevalence of 7day postoperative AKI (i.e., AKI-7day) among 2,911 adult 
surgical patients was approximately 40% (prevalence of 3day and overall AKI were 34% 
and 46%, respectively). The predictive performance of the proposed model is better 
than the preoperative data only model. For AKI-7day outcome: AUC was 0.86 (accuracy 
was 0.78) from the proposed model, while the preoperative AUC was 0.84 (accuracy 
0.76). Furthermore, with the integration of intraoperative features, we were able to 
classify patients who were misclassified in the preoperative model. According to the NRI 
statistic, there was a significant improvement in reclassification: NRI for AKI-3day was 
8%, AKI-7day was 7%, and AKI-overall was 4%. 
Conclusions: We proposed an intelligent machine learning model that is able to 
improve patients’ postoperative AKI risk score by taking the intraoperative features into 
account. Further research can address other post-surgical complications as well as 
validation of proposed system on external datasets. 
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INTRODUCTION 
Acute kidney injury (AKI), previously known as acute renal failure, is one of the most 
common postoperative complication of many inpatient procedures (1). AKI is associated 
with increased risk of morbidity, mortality and with high financial costs due to prolonged 
hospital stay (2, 3). AKI has been growing significantly at a rate of 14% per year since 
2001 and the in-hospital deaths due to AKI rose by 16% in the US between 2001 and 
2011 (4). Early detection of perioperative AKI risk is clinically challenging and accurate 
prediction of AKI has garnered a significant attention recently.  
A number biomarkers − NGAL, Cys-C, KIM-1, IL-18, L-FABP, etc. (5)  − have 
been proposed for early detection of AKI based on serum, plasma or urine. However, 
some biomarkers (e.g., NGAL) reflects the severity of disease than being specific to the 
kidney injury and some of them are not significantly better than the standard clinical 
evaluations in early stages (6). Also, applying biomarkers to low risk patients will 
increase the health care cost, hence they are rarely used in everyday practice. With the 
advancement of technology and availability of abundant electronic health records 
(EHR), a number of predictive models also have been developed to estimate 
postoperative AKI risk in different clinical settings (7). Most of the existing AKI risk score 
calculators are limited to the preoperative factors (8), applicable only to a specific 
surgery type (9, 10). Some of the available online prognostic calculators (11) are 
designed only for ICU patients (under surgical or medical category) without taking any 
surgical features into account. However, several studies have investigated the 
association between intraoperative data (such as the duration of MAP (Figure 1) in (12) 
and combination of low haemoglobin and severe hypotension in (13)) and the risk of 
AKI. The AKI prediction model in (14) integrates only few intraoperative variables (i.e., 
procedure duration, fluid balance, plasma and platelet transfusion) and specific to 
vascular surgeries.  
Therefore, the majority of existing perioperative AKI risk models do not fully 
utilize the available rich physiologic intraoperative data found in EHR. Thus, there is a 
need for intelligent, accurate, and robust systems, able to leverage information from 
operative period to predict postoperative AKI risk. The aim of this study was to develop 
a machine learning algorithm that could integrate the intraoperative features and 
improve the classification performance of preoperative prediction models.  
 
METHODS 
The method of this study has been designed to evaluate the effectiveness and 
efficiency of AKI prediction before and after a major surgery with the integration of 
intraoperative data. The study was designed and approved by the Institutional Review 
Board of the University of Florida and the University of Florida Privacy Office. The 
statistical analysis and machine learning were performed using Python, R, and SAS 
software.   
 
Data source  
Using the University of Florida Integrated Data Repository, we have previously 
assembled a single center cohort of perioperative patients by integrating multiple 
existing clinical and administrative databases at UF Health (8). The billing database for 
UF Health, established in 1990, provides detailed information on patient demographics, 
outcomes, comprehensive hospital charges, hospital characteristics, insurance status 
and physician identity. International Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9-CM) codes for up to fifty diagnoses and procedures are listed for 
each admission. We included all patients admitted to the hospital for longer than 24 
hours following any type of operative procedure between January 1, 2000 and 
November 30, 2010. This dataset was integrated with the laboratory, pharmacy and 
blood bank databases and intraoperative database (Centricity Perioperative 
Management and Anesthesia, General Electric Healthcare, Inc.) to create a 
comprehensive perioperative database for this study.  
 
Participants  
We identified patients with age greater or equal to 18 years admitted to the hospital for 
longer than 24 hours following any type of inpatient operative procedure between 
January 1, 2000 and November 30, 2010. We chose only the first procedure of patients 
with multiple surgeries for further analysis. We excluded patients with chronic kidney 
disease (CKD) stage five on admission as identified by the previously validated ICD-9-
CM diagnostic and procedure codes and those with missing serum creatinine, resulting 
in a 2,911 patient population for the analysis. We obtained institutional review board 
approval through the UF Gainesville Health Science Center Institutional Review Board 
and UF Privacy Office (#5-2009). 
 
Outcomes 
Main outcome of interest is postoperative acute kidney injury defined using the recent 
KDIGO (Kidney Disease: Improving Global Outcomes) criteria.  A non end-stage renal 
disease patient (non-ESRD) will be diagnosed by AKI if one of the following holds: (1) If 
patient is undergoing a renal replacement therapy; (2) if a measured creatinine value in 
blood exceeds 1.5 times of the baseline of the creatinine (in blood) for the patient; (3) if 
the creatinine (in blood) has an increment of at least 0.3mg/dl with in 48-hour period. 
The baseline creatinine value determines the normal creatinine value for the patient 
based on the creatinine values measured in the past one year. If the patient is not 
diagnosed with chronic kidney disease, the modification of diet in renal disease study 
(MDRD) equation was used determine the baseline creatinine value. The AKI status 
(yes/no) during the first 3 postoperative days (i.e., AKI-3day), during the 7 postoperative 
days (i.e., AKI-7day), and during the whole postoperative time up to the discharge date 
(i.e., AKI-overall) were used as outcome variables in this study.   
 
Predictor Features 
We derived features for preoperative and intraoperative variables (SDC Table 1) 
separately. For the preoperative stage, we derived predictor features from available 
demographic, socio-economic, administrative, clinical, pharmacy and laboratory 
variables. Preoperative comorbidities were derived using the ICD-9-CM codes as binary 
variables and with the Charlson comorbidity index. Also, the primary procedure type 
was modeled based on the ICD-9-CM codes with a forest structure, where each node 
represents a group of procedures, with roots representing most general groups of 
procedures and leaf nodes representing specific procedures. 
For the intraoperative stage, we derived statistical features such as minimum, 
mean, maximum, short and long term variability (15) from major physiologic time series 
(e.g., mean arterial blood pressure (MAP), systolic blood pressure, diastolic blood 
pressure, minimum alveolar concentration (MAC), and heart rate (HR)). In addition, 
abnormal value percentages, value counts, and variances have been used as features 
for laboratory variables.  Intraoperative medications and other operative characteristics 
(e.g., procedure durations, anesthesia type, etc.) also have been included to the 
intraoperative predictors.  
Predictive Analytics Workflow 
 
The proposed intraoperative data embedded preoperative model consists of two main 
layers: Preoperative and intraoperative (Figure 2). Each layer contains three main 
cores: Data transformer, data engineering, and data analytics. 
Data Transformer: 
 
Data from various sources are integrated into longitudinal cohorts inside the data 
transformer layer before direct them to the data engineering layer.  
Data Engineering:  
 
Primarily, variable generation and data preprocessing were performed in the data 
engineering layer. After generating new variables from the raw data, we cleaned 
variables following common set of rules. In particular, for the time series variables in the 
intraoperative layer, observations were first truncated to fit the corresponding surgery 
start and stop times for each patient. All extreme values were replaced by average of 
their five nearest neighbors. Isolated peaks and valleys due to any mechanical 
malfunctions were replaced by moving average values from the baseline time series. 
After the cleanup, we extracted various statistical features (e.g., minimum, mean, 
maximum, short and long term variability) from time series data (15).  
Medications and laboratory results during the surgery were also extracted and 
cleaned for the intraoperative model building. In particular, the outlier detection and 
removal for all continuous variables were performed by replacing the top and bottom 1% 
of data using random uniform values generated from 95%-99.5% and 0.5%-5% 
percentiles, respectively. Categorical variables with more than five levels were modeled 
with conditional probabilities for a patient to have a particular variable value conditioning 
on the outcome.  
Data Analytics:  
 
Preoperative data only model: Based on our previous study (16), multivariable modeling 
of the association between preoperative variables and AKI was performed using 
generalized additive models (GAM) with logistic link function (17, 18). All models were 
adjusted for non-linearity of covariates using nonlinear risk functions estimated with thin 
plate regression splines (19). The best GAM model was picked using a 5-fold cross 
validation technique and the preoperative prediction scores were generated as the 
output.  
Intraoperative data embedded preoperative model: To enrich the predictions from GAM 
model, here we proposed to use preoperative prediction scores as a new feature to the 
intraoperative model (stacking technique). All the intraoperative statistical features along 
with the preoperative prediction scores underwent a univariate analysis and only 
statistically significant (based on the F-test statistic) features were considered for the 
random forest (RF) model (20). In particular, the feature selection and other hyper 
parameters in scikit-learn (21) random forest classifier (i.e., number of trees, maximum 
features for the best split, minimum number of samples required to be at a leaf node) 
were tuned simultaneously using a grid search technique with 5 fold cross validation. 
 
Model Validation 
 
Along with the preoperative data only model and the intraoperative data incorporated 
preoperative prediction score model, we trained two other models, i.e., intraoperative 
data only RF model and full preoperative data embedded intraoperative RF model using 
70% of data to evaluate the efficiency and effectiveness of our proposed method.  
All the models are validated using the remaining 30% of testing data cohort of size 873 
patients. We assessed each model’s discrimination using the area under receiver 
operating characteristic curves (AUROC). For stratification, the optimal cut-off points 
were calculated based on the maximum Youden’s index value (22) computed during the 
training process for each outcome. As a result, patients were classified to two different 
categories: low risk and high risk patients. Also, we built the classification table from 
which we calculated accuracy, sensitivity, specificity, and positive and negative 
predictive values for each model. In addition, the net reclassification improvement (NRI) 
index (23) was used to quantify how well our proposed model reclassifies AKI patients 
over the existing preoperative data only models. We used bootstrap sampling to obtain 
95% confidence intervals for all the performance metrics.  
 
RESULTS 
 
All input variables are described in SDC Table 1 and overall cohort is summarized 
based on the outcomes in Table 1 (AKI-7day) and SDC Table 2 (AKI-3day and AKI-
overall). 
Preoperative and intraoperative baseline characteristics of participants: 
Among 2,911 patients, approximately 60% of the population were male. The median 
age of patients who developed AKI-7day was 63 years, in which 65% of them are male. 
Other than the demographic features, socio-economic characteristic of AKI patients 
were similar to those with no AKI except the distance from residency to hospital. The 
prevalence of 7day postoperative AKI was approximately 40% (prevalence of 3day and 
overall AKI are 34% and 46%, respectively). The distribution of AKI outcomes did not 
significantly differ between training and testing cohorts: 34% (training) and 35% (testing) 
for AKI-3day patients; 39% (training) and 41% (testing) for AKI-7day patients; 45% 
(training) and 48% (testing) for AKI-overall patients. Patients with any degree of 
presenting comorbidity (from CCI) and especially those with documented CKD (on 
admission) were more likely to develop AKI -- 80% of CKD patients got AKI during the 
first 7 postoperative days. Admission features such as weekend admission, admission 
source, admitting type, and operative features such as surgery type, time to surgery 
from the admission, total surgery time, and night/day surgery are statistically different 
(p-value < 0.05) among AKI and no AKI patients. Admission day medications (only 
except the betablockers) as well as the intraoperative medications (i.e., diuretic and 
pressors) have a direct impact on getting AKI or no AKI. 
 According to the physiologic intraoperative time series analysis, patients with 
AKI-7day were more likely to have a lower base signal mean value for MAP compared 
to those without AKI. However, the same AKI-7day patients were more likely to have a 
higher base signal mean value for HR compared to those without AKI. Furthermore, 
95% confidence interval for HR values is narrower for patients with AKI (Figure 3).  
 
The predictive performance of the proposed model (i.e., only integrating the 
preoperative prediction scores with intraoperative features) is better than the existing 
preoperative data only model (Figure 4A). In particular, for AKI-7day outcome, AUROC 
is 0.86 for the proposed model, while the preoperative AUROC is 0.84 (accuracy is 0.78 
for the proposed model, while the preoperative accuracy is 0.76). The complete 
performance of the proposed model over the preoperative data only model for the 
testing cohort with 95% confidence intervals is given in Table 2. The AUROC value 
comparison for all 4 models (i.e., intraoperative data only model, preoperative data only 
model, the model with preoperative prediction scores integrated with intraoperative 
features, and model with the full set of preoperative features integrated with 
intraoperative features) are given in Figure 5. Even though the AUROC of the full set of 
preoperative feature integrated model is slightly higher than the proposed model, both 
models are comparable – training is computationally intense and time consuming for the 
full set of preoperative feature integrated model.  
Reclassification of risk groups and their characteristics: 
To evaluate the effectiveness of the intraoperative data integrated model, we 
reclassified the risk groups predicted by preoperative data only model over the 
proposed model (Figure 4 B-C and SDC Figure 2). The net reclassification improvement 
(NRI) for AKI-7day between the proposed model and the preoperative data only model 
is 7% (NRI for AKI-3day is 8% and for AKI-overall is 4%) (Table 2). 
Furthermore, patients who have been classified as AKI by the proposed model 
for the misclassified patients from the preoperative data only model, have similar MAP 
mean value as in the correctly classified patients (Figure 6 A-B). Similarly, misclassified 
high risk patients in the preoperative model have similar behavior in the MAP and blood 
products with the correctly classified patients (Figure 6 C-D). 
 
DISCUSSION 
 
In this retrospective single cohort study of 2,911 surgical patients from University of 
Florida Health between 2000 and 2010, we developed machine learning models and 
evaluated the effectiveness and efficiency of predicting the most common and serious 
postoperative complication – acute kidney injury – risk with the integration of 
intraoperative data with the preoperative data. In particular, here we have developed 
four different models (i.e., intraoperative data only model, preoperative data only model, 
intraoperative data integrated preoperative prediction score model, and model with all 
intraoperative and preoperative features) to measure the performance with each of the 
three AKI outcomes: AKI-3day, AKI-7day, and AKI-Overall.  
 This study has more strengths than the existing AKI prediction models. 
During the surgery, capturing dynamic changes of surgical complications is crucial in 
providing high quality postoperative care.  More personalized preventive management 
requires timely and accurate synthesis of large amount of clinical data – EHR, vital 
signs, laboratory results, medications, etc. – throughout the perioperative stages. 
Specifically, the existing models (9-11) do not fully utilize the available time-varying 
physiologic data during the surgery. However, the incorporation of statistically crafted 
intraoperative features through the proposed method will increase the accuracy of 
predicting AKI by 3% to 8%. According to the feature importance from the fitted random 
forest model, lactic acid, mean arterial blood pressure, systolic blood pressure, diastolic 
blood pressure, red cell distribution, platelet count, blood products, heart rate, and 
surgery time are with in the first 20 most important intraoperative predictors.  More 
importantly, the proposed method captured high AKI risk patients while they were 
classified as low risk patients from the preoperative data only models (there was a 4% 
to 8% net reclassification improvement). In addition, this proposed model will be 
embedded to our existing postoperative prediction intelligent platform in future to 
perform real time.  
This study has some limitations as well. First, we chose only the first surgery of 
patients with multiple surgeries for building the proposed predictive models. However, 
there is an opportunity to consider all surgery encounters when building the random 
forest models. Second, we only predicted AKI outcome in three different time points. We 
can extend the proposed predictive model with other postoperative outcomes – sepsis, 
respiratory failure, cardiovascular complications, etc. – as well. Moreover, these models 
have only been validated by the unseen data from the same cohort. Therefore, further 
validation is required using an external dataset.  
CONCLUSIONS 
We proposed a machine learning model based on random forest classifier that is able to 
improve patients’ postoperative AKI risk score by taking the intraoperative features into 
account. Further research can address other post-surgical complications as well as 
validation of proposed system on external datasets. 
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Figures and Figure Legends 
 
Figure 1. Mean arterial blood pressure over the time and their effect in predicting AKI: 
(A) AKI-3day, (B) AKI-7day, and (C) AKI-Overall. Note that short durations of MAP less 
than 55 mmHg are associated with AKI.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. The conceptual diagram of the intraoperative data integrated AKI prediction 
model. This diagram shows the aggregation of data transformer, data engineering, and 
data analytics modules in preoperative and intraoperative stages. In particular, we 
proposed to stack preoperative prediction scores with the cleaned and feature 
engineered intraoperative data to obtain improved prediction results for acute kidney 
injury.  
 
 
 
 
 
Figure 3. Physiologic time series variations stratified by AKI-7day outcome for 100 
randomly selected patients during the first 200min of the surgery. (A) Average of the 
mean arterial blood pressure including 95% CI for AKI and no AKI, (B) average of the 
heart rate values including 95% CI for AKI and no AKI, (C) average of the MAC values 
including 95% CI for AKI and no AKI.   
 
Figure 4. (A) ROC curves for preoperative model (AUC=0.84) and the proposed 
intraoperative data integrated model (AUC=0.86) with the AKI-7day outcome from the 
testing cohort. (B) The reclassification of true AKI-7day patients among preoperative 
model and proposed model. The proposed method reclassified false negative patients 
from preoperative model as high AKI risk patients. (C) The reclassification of true no 
AKI-7day patients between preoperative model and proposed model.  
 
 
Figure 5. AUROC value comparison among all 4 models: Intraoperative data only 
model, preoperative data only model, intraoperative data integrated preoperative 
prediction score model (proposed model), and model with all intraoperative and 
preoperative data for all three AKI outcomes: AKI-3day, AKI-7day, and AKI-Overall from 
the testing cohort.  
 
 
 
 
 
 
 
 
Figure 6. True AKI patient characteristics after reclassification. (A) Reclassification from 
proposed model for misclassified patients in preoperative model. (B) Reclassification 
from proposed model for correctly classified patients in preoperative model. Mean MAP 
of high risk patients in (A) is statistically similar to mean MAP in (B) (p-value=0.75 > 
0.05 by the Wilcoxon rank sum test). (C) Blood products (ml) vs. mean MAP for 
misclassified patients in preoperative model. (D) Blood products (ml) vs. mean MAP for 
correctly classified patients in preoperative model. Mean values of blood products and 
mean MAP for high risk patients in proposed model are statistically similar between (C) 
and (D). Note: Box represents 95% confidence intervals of the mean for the given 
variable. 
  
 
 
 
 
Tables 
 
Table 1. Summary of overall cohort stratified by acute kidney injury - 7day. 
 
    Acute Kidney Injury - 7day 
  Yes No 
  Overall (N=2,911) (N=1,163) (N=1,748) 
Demographic features    
Age, median (25th-75th) 60.0 (49.0,69.0) 63.0 (52.0,72.0)a 58.0 (47.0,67.0) 
Male gender, n(%) 1760 (60.46%) 753 (64.75%) a 1007 (57.61%) 
Race, n(%)    
  White 2374 (81.55%) 934 (80.31%) 1440 (82.38%) 
  AA 265 (9.1%) 115 (9.89%) 150 (8.58%) 
  Hispanic  117 (4.02%) 53 (4.56%) 64 (3.66%) 
  Missing  87 (2.99%) 37 (3.18%) 50 (2.86%) 
  Other  68 (2.34%) 24 (2.06%) 44 (2.52%) 
Primary insurance, n(%)a    
  Private 1208 (41.5%) 411 (35.34%) 797 (45.59%) 
  Medicare 1204 (41.36%) 569 (48.93%) 635 (36.33%) 
  Medicaid 340 (11.68%) 142 (12.21%) 198 (11.33%) 
  Uninsured 159 (5.46%) 41 (3.53%) 118 (6.75%) 
Zip (top 3 codes), n(%)a    
  32608 34 (1.17%) 12 (1.03%) 22 (1.26%) 
  32060 27 (0.93%) 12 (1.03%) 15 (0.86%) 
  32605 27 (0.93%) 6 (0.52%) 21 (1.2%) 
Socio-economic features    
Neighborhood characteristics    
Rural area, n(%) 767 (26.35%) 300 (25.8%) 467 (26.72%) 
Total population, median (25th-
75th) 
19162 
(10639,30611) 
19287 
(11056,30533) 
18931 
(10510,30611) 
Median income, median (25th-
75th) 
34372 
(29980,41410) 
34459 
(30084,41410) 
34328 
(29854,41410) 
Total proportion of African-
Americans (%), median (25th-
75th) 9.6 (3.9,17.6) 9.6(3.7,19.5) 9.5 (3.9,16.5) 
Total proportion of Hispanic (%), 
median (25th-75th) 4.2 (2.5,6.8) 4.1 (2.5,7.1) 4.3 (2.6,6.7) 
County (top 3 categories), n(%)    
  Alachua  383 (13.16%) 139 (11.95%) 244 (13.96%) 
  Marion  250 (8.59%) 73 (6.28%) 177 (10.13%) 
  Georgia  142 (4.88%) 63 (5.42%) 79 (4.52 %) 
Distance from residency to 
hospital (km), median (25th-
75th) 
68.01  
(28.9,143.19) 
72.73 
(30.69,153.35)a 
61.02  
(28.2,131.48) 
Population proportion below 
poverty (%), median (25th-75th) 12.0 (8.1,17.3) 11.8 (8.0,17.4) 12.1 (8.3,17.2) 
    
Preoperative characteristics of patients stratified by acute kidney injury 
Comorbidity features    
Charlson's comorbidity index 
(CCI), median (25th-75th) 2.0 (1.0,3.0) 2.0 (1.0,3.0)a 1.0 (0.0,3.0) 
Chronic kidney disease, n(%) 346 (11.89%) 273 (23.47%)a 73 (4.18%) 
Operative features    
Admission    
Weekend admission, n(%) 472 (16.21%) 217 (18.66%)a 255 (14.59%) 
Admission source, n(%)a    
  Outpatient setting  1753 (60.53%) 648 (55.81%) 1105 (63.69%) 
  Emergency room  583 (20.13%) 221 (19.04%) 362 (20.86%) 
  Transfer  560 (19.34%) 292 (25.15%) 268 (15.45%) 
Admission month (top 3 
categories), n(%)    
  September  279 (9.58%) 111 (9.54%) 168 (9.61%) 
  October  273 (9.38%) 99 (8.51%) 174 (9.95%) 
  June  254 (8.73%) 92 (7.91%) 162 (9.27%) 
Number of operating surgeons, n 129   
Number of procedures per 
operating Surgeon, n(%)a    
  First rank  422 (14.5%) 241 (20.72%) 181 (10.35%) 
  Second rank  267 (9.17%) 70 (6.02%) 197 (11.27%) 
  Third rank  258 (8.86%) 129 (11.09%) 129 (7.38%) 
Admitting type, n(%)a    
  surgery  2545 (87.43%) 957 (82.29%) 1588 (90.85%) 
  medicine  366 (12.57%) 206 (17.71%) 160 (9.15%) 
Emergent surgery status, n (%)a 1352 (46.44%) 604 (51.93%) 748 (42.79%) 
Surgery type, n(%)a    
  Cardiothoracic surgery  1415 (48.61%) 739 (63.54%) 676 (38.67%) 
  Other surgeries  826 (28.38%) 292 (25.11%) 534 (30.55%) 
  Neurologic Surgery  301 (10.34%) 30 (2.58%) 271 (15.5%) 
  Specialty Surgeries  243 (8.35%) 56 (4.82%) 187 (10.7%) 
  Non-Cardiac General Surgery  126 (4.33%) 46 (3.96%) 80 (4.58%) 
Time of surgery from admission 
(days) 0.0 (0.0,2.0) 1.0 (0.0,4.0)a 0.0 (0.0,1.0) 
Admission day medications, n(%)    
Diuretics 600 (20.61%) 315 (27.09%)a 285 (16.3%) 
Bicarbonate 295 (10.13%) 151 (12.98%)a 144 (8.24%) 
Angiotensin-Converting-Enzyme 
Inhibitors 351 (12.06%) 169 (14.53%)a 182 (10.41%) 
Antiemetic 1413 (48.54%) 467 (40.15%)a 946 (54.12%) 
Betablockers 872 (29.96%) 359 (30.87%) 513 (29.35%) 
Statin 502 (17.24%) 230 (19.78%)a 272 (15.56%) 
Pressors or inotropes 424 (14.57%) 223 (19.17%)a 201 (11.5%) 
 
Intraoperative characteristics of patients stratified by acute kidney injury 
Physiologic intraoperative time 
series variables, median (25th-
75th)    
Diastolic BP - maximum  140 (121,140) 140 (125,140)a 140 (120,140) 
Diastolic BP - minimum  20.0 (15.0,25.0) 20.0 (12.0,20.0)a 20.0 (17.0,30.0) 
Diastolic BP - average  58.7 (53.8,65.1) 56.4 (51.85,62.0)a 60.6 (55.6,67.0) 
Diastolic BP - long-term 
variability  10.4 (8.7,12.7) 10.7 (9.0,12.9)a 10.2 (8.4,12.6) 
Diastolic BP - short-term 
variability  4.8 (3.8,5.9) 5.0 (4.0,6.0)a 4.7 (3.7,5.8) 
Systolic BP - maximum  240.0 (209.0,240.0) 
240.0 
(215.0,240.0)a 240.0 (205.0,240.0) 
Systolic BP - minimum  40.0 (31.0,50.0) 40.0 (28.0,40.0)a 40.0 (34.0,57.0) 
Systolic BP - average of base 
signal 106.1 (93.8,118.65) 100.1 (90.3,112.9)a 110.9 (97.2,120.72) 
Systolic BP - long-term variability  19.6 (15.6,24.2) 20.8 (16.9,25.1)a 18.6 (15.0,23.3) 
Systolic BP - short-term variability 7.7 (6.1,9.5) 7.9 (6.4,9.6)a 7.7 (5.9,9.4) 
Mean Arterial BP - maximum  240 (209.0,240.0) 240 (215.0,240.0)a 240 (205.0,240.0) 
Mean Arterial BP - minimum  40.0 (31.0,50.0) 40.0 (28.0,40.0)a 40.0 (34.0,57.0) 
Mean Arterial BP - average 106.1 (93.8,118.65) 100.1 (90.3,112.9)a 110.9 (97.2,120.72) 
Mean Arterial BP - long-term 
variability 19.6 (15.6,24.2) 20.8 (16.9,25.1)a 18.6 (15.0,23.3) 
Mean Arterial BP - short-term 
variability 7.7 (6.1,9.5) 7.9 (6.4,9.6)a 7.7 (5.9,9.4) 
Heart rate - maximum  146 (125.0,171.0) 148 (128.0,175.0)a 144 (123.95,167.0) 
Heart rate - minimum  34.0 (18.0,53.0) 26.0 (17.0,47.5)a 39.0 (21.0,55.0) 
Heart rate - average 82.8 (73.8,92.7) 84.1 (74.55,94.0)a 81.9 (73.3,91.72) 
Heart rate - long-term variability 12.4 (8.6,19.3) 14.4 (9.35,21.8)a 11.5 (8.5,17.5) 
Heart rate - short-term variability 5.5 (4.2,6.6) 5.8 (4.5,6.8)a 5.3 (3.9,6.5) 
MAC - maximum  2.59 (1.71,3.42) 3.42 (1.97,3.42)a 2.56 (1.71,3.42) 
MAC - average 0.6 (0.5,0.7) 0.5 (0.5,0.7) 0.6 (0.5,0.7) 
MAC - long-term variability 0.3 (0.2,0.4) 0.3 (0.2,0.5)a 0.3 (0.2,0.4) 
    
Intraoperative laboratory 
results, median (25th-75th)    
Carboxyhemoglobin in arterial - 
maximum 2.2 (1.4,3.0) 2.3 (1.45,3.1)a 2.1 (1.3,2.9) 
Carboxyhemoglobin in arterial - 
mean 1.95 (1.3,2.75) 2.1 (1.4,2.87)a 1.85 (1.2,2.67) 
Carboxyhemoglobin in arterial - 
minimum 1.6 (1.1,2.55) 1.8 (1.2,2.7)a 1.5 (1.0,2.5) 
Carboxyhemoglobin in arterial - 
variance 0.0 (0.0,0.08) 0.0 (0.0,0.077) 0.0 (0.0,0.08) 
Bicarbonate in Arterial - 
maximum 23.3 (21.7,25.0) 23.3 (21.7,25.2) 23.3 (21.7,24.9) 
Bicarbonate in Arterial - mean 22.65 (21.18,24.4) 22.65 (21.06,24.4) 22.65 (21.2,24.4) 
Bicarbonate in Arterial - 
minimum 22.0 (20.4,24.05) 22.0 (20.25,24.0) 22.1 (20.6,24.1) 
Bicarbonate in Arterial - variance 0.0 (0.0,0.84) 0.0 (0.0,1.22) 0.0 (0.0,0.72) 
Hematocrit - maximum 31.5 (28.7,34.9) 31.4 (28.5,34.8) 31.6 (28.8,35.0) 
Hematocrit - mean 30.8 (28.0,34.1) 30.6 (27.78,33.8)a 30.9 (28.16,34.3) 
Hematocrit -minimum 30.2 (27.1,33.6) 29.9 (26.7,33.3)a 30.5 (27.4,33.9) 
Hematocrit - variance 0.0 (0.0,1.12) 0.0 (0.0,1.28) 0.0 (0.0,1.12) 
Hemoglobin in arterial - 
maximum 11.0 (10.0,12.2) 11.0 (9.9,12.2) 11.1 (10.1,12.2) 
Hemoglobin in arterial - mean 10.55 (9.6,11.8) 10.45 (9.5,11.64)a 10.7 (9.7,11.9) 
Hemoglobin in arterial - 
minimum 10.2 (9.0,11.6) 10.1 (8.8,11.5)a 10.3 (9.2,11.7) 
Hemoglobin in arterial - variance 0.0 (0.0,0.44) 0.0 (0.0,0.56) 0.0 (0.0,0.4) 
Lactic acid - maximum 2.5 (1.5,4.2) 3.4 (2.0,5.2)a 2.1 (1.3,3.32) 
Lactic acid - mean 2.2 (1.4,3.57) 2.83 (1.8,4.6)a 1.77 (1.2,2.82) 
Lactic acid - minimum 1.6 (1.1,2.9) 2.2 (1.3,4.0)a 1.4 (1.0,2.4) 
Lactic acid -variance 0.0 (0.0,0.25) 0.0 (0.0,0.47) 0.0 (0.0,0.18) 
Mean corpuscular hemoglobin 
concentration - maximum 34.5 (33.5,35.5) 34.5 (33.6,35.5) 34.4 (33.5,35.5) 
Mean corpuscular hemoglobin 
concentration - mean 34.3 (33.4,35.3) 34.3 (33.5,35.3) 34.3 (33.3,35.3) 
Mean corpuscular hemoglobin 
concentration - minimum 34.1 (33.2,35.1) 34.2 (33.3,35.1) 34.1 (33.2,35.1) 
Mean corpuscular hemoglobin - 
maximum 30.6 (29.4,31.8) 30.5 (29.4,31.8) 30.6 (29.4,31.8) 
Mean corpuscular hemoglobin - 
mean 30.4 (29.26,31.67) 30.4 (29.3,31.6) 30.45 (29.25,31.7) 
Mean corpuscular hemoglobin - 
minimum 30.3 (29.1,31.5) 30.2 (29.1,31.5) 30.3 (29.1,31.52) 
Mean corpuscular hemoglobin - 
variance 0.0 (0.0,0.04) 0.0 (0.0,0.04) 0.0 (0.0,0.05) 
Mean corpuscular volume - 
maximum 88.6 (85.2,92.2) 88.7 (85.25,92.2) 88.4 (85.2,92.2) 
Mean corpuscular volume - mean 88.23 (85.0,91.8) 88.3 (85.0,91.59) 88.2 (85.1,91.94) 
Mean corpuscular volume - 
minimum 87.9 (84.7,91.4) 87.9 (84.7,91.0) 87.9 (84.8,91.7) 
Methemoglobin - max 0.8 (0.6,1.0) 0.8 (0.6,1.0)a 0.8 (0.6,0.9) 
Methemoglobin - mean 0.7 (0.52,0.9) 0.7 (0.55,0.9)a 0.7 (0.5,0.8) 
Methemoglobin - minimum 0.6 (0.4,0.8) 0.6 (0.4,0.9)a 0.6 (0.4,0.8) 
Methemoglobin - variance 0.0 (0.0,0.023) 0.0 (0.0,0.024) 0.0 (0.0,0.022) 
Mean Platelet Volume - 
maximum 8.0 (7.5,8.7) 8.2 (7.6,8.8)a 7.9 (7.4,8.5) 
Mean Platelet Volume - mean 7.9 (7.4,8.5) 8.07 (7.5,8.69)a 7.8 (7.3,8.4) 
Mean Platelet Volume - 
minimum 7.8 (7.3,8.4) 7.9 (7.4,8.55)a 7.7 (7.2,8.3) 
Mean Platelet Volume - variance 0.0 (0.0,0.03) 0.0 (0.0,0.02) 0.0 (0.0,0.04) 
O2 Content, Arterial - maximum 15.3 (14.0,16.95) 15.2 (13.8,16.9)a 15.4 (14.1,17.0) 
O2 Content, Arterial - mean 14.7 (13.4,16.3) 14.5 (13.2,16.1)a 14.8 (13.5,16.4) 
O2 Content, Arterial - minimum 14.2 (12.5,16.0) 14.0 (12.25,15.8)a 14.3 (12.8,16.1) 
O2 Content, Arterial - variance 0.0 (0.0,0.91) 0.0 (0.0,1.03) 0.0 (0.0,0.81) 
O2 saturation - max 99.8 (99.0,100) 99.9 (99.0,100) 99.8 (99.0,100) 
O2 saturation - mean 99.5 (98.4,100) 99.55 (98.41,100) 99.41 (98.4,100) 
O2 saturation - minimum 99.3 (97.8,100) 99.4 (97.8,100) 99.2 (97.8,100) 
O2 saturation - variance 0.0 (0.0,0.02) 0.0 (0.0,0.01) 0.0 (0.0,0.02) 
Partial pressure of carbon dioxide 
- maximum 42.8 (38.4,47.2) 43.1 (38.85,47.5) 42.8 (38.2,47.0) 
Partial pressure of carbon dioxide 
- mean 40.8 (36.9,45.2) 40.86 (37.2,45.38)a 40.8 (36.7,45.0) 
Partial pressure of carbon dioxide 
- minimum 38.9 (34.55,44.6) 39.5 (34.8,44.8)a 38.8 (34.38,44.4) 
Partial pressure of carbon dioxide 
- variance 0.0 (0.0,6.46) 0.0 (0.0,6.48) 0.0 (0.0,6.29) 
PF-ratio 90.4 (74.87,118.68) 87.7 (73.87,114)a 91.92 (75.64,122.31) 
pH - maximum 7.38 (7.33,7.43) 7.38 (7.32,7.43) 7.38 (7.34,7.43) 
pH - mean 7.36 (7.32,7.4) 7.36 (7.32,7.4)a 7.36 (7.33,7.41) 
pH - minimum 7.34 (7.3,7.39) 7.34 (7.3,7.38)a 7.34 (7.31,7.39) 
Platelet count - maximum 180  (133,239) 163 (117,209)a 197 (145,253) 
Platelet count - mean 175 (128,229) 156 (110,203)a 190 (140,245) 
Platelet count - minimum 171 (121,223) 151 (104,198)a 184 (135,240) 
Platelet count - variance 0.0 (0.0,78.1) 0.0 (0.0,60.5)a 0.0 (0.0,84.9) 
Red blood cells - maximum 3.59 (3.23,3.97) 3.57 (3.22,3.94) 3.6 (3.25,3.98) 
Red blood cells - mean 3.5 (3.16,3.87) 3.46 (3.12,3.85)a 3.52 (3.19,3.9) 
Red blood cells - minimum 3.42 (3.07,3.83) 3.38 (3.0,3.8)a 3.45 (3.11,3.85) 
Red blood cells - variance 0.0 (0.0,0.02) 0.0 (0.0,0.02) 0.0 (0.0,0.01) 
Red cell distribution width - 
maximum 14.9 (13.9,16.1) 15.3 (14.4,16.7)a 14.6 (13.7,15.7) 
Red cell distribution width - 
mean 14.8 (13.84,15.95) 15.2 (14.4,16.5)a 14.5 (13.6,15.5) 
Red cell distribution width - 
minimum 14.7 (13.8,15.9) 15.1 (14.2,16.4)a 14.4 (13.6,15.5) 
Red cell distribution width - 
variance 0.0 (0.0,0.01) 0.0 (0.0,0.02) 0.0 (0.0,0.01) 
White blood cells - maximum 13.6 (9.85,18.3) 14.0 (9.8,19.25)a 13.3 (9.9,17.8) 
White blood cells - mean 12.85 (9.3,17.52) 13.3 (9.2,18.3)a 12.51 (9.33,16.9) 
White blood cells - min 12.1 (8.5,16.9) 12.6 (8.4,17.7)a 11.7 (8.5,16.3) 
White blood cells - variance 0.0 (0.0,0.85) 0.0 (0.0,0.54)a 0.0 (0.0,1.07) 
Total blood products in ml 318 (0.0,1250) 750.0 (0.0,2500)a 0.0 (0.0,750) 
Total estimated blood loss in ml 150 (150,500) 150 (150,350)a` 150 (150,500) 
Total fluids in ml 2300 (1400,3600) 2200 (1250,3500)a 2435 (1500,3700) 
Total urine output in ml 650 (300,1150) 700 (350,1200)a 600 (300,1100) 
    
Intraoperative medications, n(%)    
Diuretic (vs. No) 329 (11.3%) 210 (18.06%)a 119 (6.81%) 
Pressors (vs. No) 1942 (66.71%) 858 (73.77%)a 1084 (62.01%) 
    
Other variables    
Total surgery time in mins, 
median (25th-75th) 387 (293,483) 425 (340,521)a 357 (271,449) 
Night surgery (vs. No), n(%) 394 (13.53%) 184 (15.82%)a 210 (12.01%) 
General anesthesia (vs. BL/BM), 
n(%) 2881 (98.97%) 1153 (99.14%) 1728 (98.86%) 
a p-value < 0.05 compared to no AKI-7day group.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Performance of the proposed intraoperative data integrated model over the 
preoperative data only model for the testing cohort with 95% confidence intervals. 
 
Outcome Model AUC Accuracy Sensitivity Specificity PPV NPV NRI 
AKI- 
3Day 
Preop 
model 
0.833 
[0.804, 0.861] 
0.703  
[0.674, 0.732] 
0.824 
[0.778, 0.866] 
0.638 
[0.600, 0.677] 
0.551  
[0.504, 0.596] 
0.870  
[0.833, 0.900] 
8.14%  
[0.04, 
0.13] 
p <0.05 
Proposed 
model 
0.845 
[0.817, 0.873] 
0.771  
[0.739, 0.796] 
0.775 
[0.729,0.820] 
0.769 
[0.734,0.803] 
0.644  
[0.595, 0.693] 
0.863  
[0.830, 0.893] 
AKI- 
7Day 
Preop 
model 
0.844 
[0.818, 0.870] 
0.762 
 [0.732, 0.786] 
0.681 
[0.637, 0.731] 
0.818 
[0.783, 0.849] 
0.726  
[0.675, 0.770] 
0.785 
[0.745, 0.818] 
7.14% 
[0.03,  
0.12] 
p <0.05 
Proposed 
model 
0.860 
[0.835, 0.886] 
0.784  
[0.753,0.808] 
0.798 
[0.756, 0.837] 
0.773 
[0.738, 0.809] 
0.713 
[0.671,0.757] 
0.844 
[0.809, 0.874] 
AKI-
Overall 
Preop 
model 
0.837 
[0.811, 0.863] 
0.764 
 [0.734, 0.792] 
0.697 
[0.654,0.742] 
0.826 
[0.798,0.859] 
0.787 
[0.742, 0.827] 
0.747 
[0.708, 0.785] 
3.82%  
[0.002, 
0.08] 
p <0.05 
Proposed 
model 
0.854 
[0.828, 0.879] 
0.778  
[0.748, 0.803] 
0.795 
[0.757,0.833] 
0.762 
[0.723,0.800] 
0.755  
[0.714, 0.792] 
0.801 
[0.759, 0.836] 
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SDC Figure 1. The flow diagram of the random forest model used to train and test the 
perioperative data along with three different AKI outcomes: AKI-3day, AKI-7day, and 
AKI-Overall. The cohort of size 2,911 with 231 features were randomly split in to 70% 
train and 30% test cohorts. A random forest classifier was used to train the AKI 
predication model (we used 5-fold CV for hyper parameter tuning and feature selection) 
for all three outcomes and performance were tested using the testing cohort. 
 
 
 
SDC Figure 2. (A) ROC curves for preoperative model (AUC=0.83) and the proposed 
intraoperative data integrated model (AUC=0.85) with the AKI-3day outcome. (B-C) The 
reclassification patients among preoperative model and proposed model for AKI-3day 
and no AKI-3day patients, respectively. (D) ROC curves for preoperative model 
(AUC=0.84) and the proposed intraoperative data integrated model (AUC=0.85) with the 
AKI-overall outcome. (E-F) The reclassification of patients between preoperative model 
and proposed model for AKI-overall and no AKI-overall patients, respectively. 
 
 
 
 
 
 
 
SDC Table 1. Characteristics of input variables. 
 
Variable 
Type of 
Variable 
Data 
Source 
Number of 
categories 
Type of Preprocessing 
Demographic variables          
Age (years) Continuous Derived   
Imputation of outliersa; 
Nonlinear functionb 
Gender Binary Raw 2   
Race Nominal Raw 5 
Optimization of categorical 
featuresc 
Socioeconomic variables         
Primary Insurance  Nominal Raw 4 
Optimization of categorical 
featuresc 
Residency area characteristics         
Zip code Nominal Raw 10,000 
Transformation through 
link to Census datad 
County Nominal Raw 71 
Optimization of categorical 
featuresc 
Rural area Binary Derived 2   
Total Population Continuous Derived   
Obtained  using residency 
zip code with linkage to US 
Census datad;  Imputation 
of outliersa 
Median Income Continuous Derived   
Obtained  using residency 
zip code with linkage to US 
Census datad;  Imputation 
of outliersa  
Total Proportion of African- 
Americans 
Continuous Derived   
Obtained  using residency 
zip code with linkage to US 
Census datad;  Imputation 
of outliersa  
Total Proportion of Hispanic Continuous Derived   
Obtained  using residency 
zip code with linkage to US 
Census datad;  Imputation 
of outliersa  
Population Proportion Below 
Poverty 
Continuous Derived   
Obtained  using residency 
zip code with linkage to US 
Census datad;  Imputation 
of outliersa  
Distance from Residency to 
Hospital (km)  
Continuous Derived   
Calculated  using residency 
zip code;  Imputation of 
outliersa 
Operative characteristics         
Day of admission Nominal Derived 7 
Optimization of categorical 
featuresc 
Month of admission Nominal Derived 12 
Optimization of categorical 
featuresc 
Year of admission Nominal Derived 11 
Optimization of categorical 
featuresc 
     
Weekend admission Binary Derived 2   
Attending Surgeon Nominal Raw 520 
Optimization of categorical 
featuresc 
Admission Source Nominal Raw 3 
Optimization of categorical 
featuresc 
Admission Type 
(Emergent/Elective) 
Binary Raw 2   
Admitting type 
(Medicine/Surgery) 
Binary Derived 2   
Admitting Service  Nominal Derived 46 
Optimization of categorical 
featuresc 
Surgery Type  Nominal Derived 5 
Optimization of categorical 
featuresc 
Time of surgery from admission 
(days) 
Continuous Derived  
 Imputation of outliersa; 
Nonlinear functionb 
Diagnosis/Procedure         
Primary surgical procedure  Nominal Derived 1555 
Forest tree analysis of ICD9 
codese 
Major Diagnosis Category  Nominal Raw 28 
Optimization of categorical 
featuresc 
Comorbidities         
Charlson's comorbidity index  Nominal Derived 18 
Optimization of categorical 
featuresc 
Number of diagnosis Continuous Derived  
 Imputation of outliersa; 
Nonlinear functionb 
Myocardial Infarction Binary Derived 2   
Congestive Heart Failure Binary Derived 2   
Peripheral Vascular Disease Binary Derived 2   
Cerebrovascular Disease Binary Derived 2   
Chronic Pulmonary Disease Binary Derived 2   
Diabetes Binary Derived 2   
Cancer Binary Derived 2   
Liver Disease Binary Derived 2  
Valvular disease Binary Derived 2   
Hypothyroidism Binary Derived 2   
Coagulopthy Binary Derived 2   
Obesity Binary Derived 2   
Weight loss Binary Derived 2   
Fluid and electrolyte disorders Binary Derived 2   
Chronic anemia Binary Derived 2   
Alcohol or drug abuse Binary Derived 2   
Depression Binary Derived 2   
Hypertension Binary Derived 2   
Chronic kidney disease Binary Derived 2   
End Stage Renal disease Binary Derived 2   
Admission day Medicationsf         
Number of Medications on 
Admission 
Continuous Derived  
Imputation of outliersa; 
Nonlinear functionb 
Betablockers Binary Derived 2   
Diuretics Binary Derived 2   
Statin Binary Derived 2   
Aspirin Binary Derived 2   
Angiotensin-Converting-Enzyme 
Inhibitors 
Binary Derived 2   
Pressors or inotropes Binary Derived 2   
Bicarbonate Binary Derived 2   
Antiemetic Binary Derived 2   
Aminoglycosides Binary Derived 2  
Steroids Binary Derived 2  
Vancomycin Binary Derived 2  
Nonsteroidal anti-inflammatory 
drug 
Binary Derived 2  
Number of Nephrotoxic 
Medications 
Continuous Derived  
Imputation of outliersa; 
Nonlinear functionb 
Preoperative laboratory results         
Reference estimated glomerular 
filtration rate 
Continuous Derived   
Imputation of outliersa ; 
Nonlinear functionb 
Ratio of reference creatinine to 
MDRD Cr  
Continuous Derived   Imputation of outliersa 
Hemoglobin, g/dl Continuous Raw   
Imputation of outliersa ; 
Nonlinear functionb 
Automated urinalysis,  urine 
protein, mg/dL 
Nominal Derived 3 
Optimization of categorical 
featuresc  
Automated urinalysis, urine 
hemoglobin, mg/dL 
Nominal Derived 3 
Optimization of categorical 
featuresc  
Automated urinalysis, urine 
glucose, mg/dL 
Nominal Derived 3 
Optimization of categorical 
featuresc 
No of complete blood count 
tests 
Nominal Derived 3 
Optimization of categorical 
featuresc 
 
Physiologic intraoperative time 
series 
    
Mean arterial blood pressure 
(Invasive), mmHg 
Continuous Raw  
Data cleaningg; Imputation 
of outliersh; Statistical 
features extractioni 
Systolic blood pressure 
(Invasive), mmHg 
Continuous Raw  
Data cleaningg; Imputation 
of outliersh; Statistical 
features extractioni 
Diastolic blood pressure 
(Invasive), mmHg 
Continuous Raw  
Data cleaningg; Imputation 
of outliersh; Statistical 
features extractioni 
Minimum alveolar 
concentration 
Continuous Raw  
Data cleaningg; Imputation 
of outliersh; Statistical 
features extractioni 
Heart rate, bpm Continuous Raw  
Data cleaningg; Imputation 
of outliersh; Statistical 
features extractioni 
Peripheral capillary oxygen 
saturation (SPO2) 
Continuous Raw  
Data cleaningg; Imputation 
of outliersh 
 
 
    
Laboratory results on surgery      
pH Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Lactic acid, mmol/L Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Hemoglobin, g/dL Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Hematocrit, vol% Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Partial pressure of oxygen 
(PO2)- Arterial, mmHg 
Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Fraction of inspired oxygen 
(FIO2) 
Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
PF-ratio Continuous Derived  
Missing data imputationl; 
Outlier removala 
Mean corpuscular hemoglobin, 
pg/[red cell] 
Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Mean corpuscular hemoglobin 
concentration, g/dL 
Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Mean corpuscular volume, 
fl/[red cell]L 
Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Red Blood Cells, million 
cells/mcL 
Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Red Cell Distribution Width, % Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
White Blood Cells, 10*9/L Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Mean Platelet Volume, fL Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Platelets Count, 10*9/L Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Carboxyhemoglobin-Arterial, % Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
oxygen Content-Arterial, % Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
oxygen saturation, % Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Bicarbonate-Arterial, mmol/L Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Methemoglobin, % Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
Partial pressure of Carbon 
dioxide, mmHg 
Continuous Raw  
Missing data imputationj; 
Statistical features 
extractionk; Outlier 
removala 
     
Medications on surgery     
Pressors Binary Derived 2  
Diuretic Binary Derived 2  
 
Other characteristics 
    
Anesthesia type Nominal Raw 2  
Duration of surgery, min Continuous Derived  Outlier removala 
Estimated blood loss, mL Continuous Raw  Outlier removala 
Urine output, mL Continuous Raw  Outlier removala 
Fluid, mL Continuous Raw  Outlier removala 
Blood product, mL Continuous Raw  Outlier removala 
 
Abbreviation: MDRD, Modification of Diet in Renal Disease.  
 
MDRD formula for creatinine was calculated using (186/GFR) * (0.742*[if female])*(1.21*[if black])* age(-
0.203)] (1/1.154)  assuming GFR=75. 
 
PF-ratio was calculated using PO2/FIO2. 
 
Different set of variables were kept in final models (preoperative or intraoperative) from the input set 
provided in the table. 
 
a For continuous variables, observations that fell in the top and bottom 1% of the distribution were 
considered as outliers and imputed by neighborhood values (i.e., above 99% are imputed randomly from 
a uniform distribution defined over [95%, 99.5%] percentiles and below 1% are imputed randomly from 
another uniform distribution defined over [0.5%, 5%] percentiles. 
 
b Nonlinear risk function was calculated for continuous functions entered to the preoperative models. 
 
c For categorical variables with more than five levels, levels were transformed to a numeric value as 
detailed in Methods section. 
 
d Using residency zip code, we linked to US Census data to calculate residing neighborhood 
characteristics and distance from hospital. 
 
e Surgical procedure codes were optimized using forest tree analysis of ICD-9-CM codes as detailed in 
Methods section. 
 
f Medications were dispensed on the first admission day using RxNorms data grouped into drug classes 
according to the US, Department of Veterans Affairs National Drug File-Reference Terminology. 
 
g We used observations for the first surgery, in case multiple surgeries exist. We averaged values if 
multiple observations exist at a time point. Only accounts with more than 30 observations were 
considered.  
 
h Values out of the predefined ranges were removed. Additionally, values in the top and bottom 0.5% of 
each of the time series distributions were removed. 
 
i We extracted several descriptive statistical measures, i.e. mean and standard deviation of base signal 
and standard deviation of residual signal (Saria et al., 2010) of time series, minimum and maximum 
values observed, time/percentage of time a patient spent in a specific range of values for each of the time 
series.  
  
j Observations during the first surgery have been considered. Missing values were imputed using surgery 
day observations for the given account.  
 
k We extracted descriptive statistical features, i.e., minimum, mean, maximum, count, variance, abnormal 
observation percentage (%) = abnormal value count/ total observations * 100.    
 
l Missing PF-ratios are replaced by (SF-ratio – 64)/0.84, where SF-ratio = SPO2/FIO2.  
 
 
 
 
 
 
 
 
 
 
SDC Table 2. Summary of overall cohort stratified for AKI-3day and AKI-Overall by 
acute kidney injury. 
 
    Acute Kidney Injury - 3day Acute Kidney Injury - Overall 
  No Yes No Yes 
  
Overall 
(N=2,911) (N=1,913) (N=998) (N=1,572) (N=1,339) 
Demographic features      
Age, median (25th-75th) 60.0 (49.0,69.0) 58.0 (47.0,68.0) 63.0 (52.0,72.0)a 58.0 (46.0,67.0) 63.0 (52.0,71.5)a 
Male gender, n (%) 1760 (60.4%) 1101 (57.5%) 659 (66.0%)a 898 (57.1 %) 862 (64.3 %)a 
Race, n (%)      
  White 2374 (81.5%) 1579 (82.5 %) 795 (79.6 %) 1295 (82.3 %) 1079 (80.5 %) 
  AA 265 (9.10%) 167 (8.73 %) 98 (9.82 %) 133 (8.46 %) 132 (9.86 %) 
  Hispanic  117 (4.02%) 66 (3.45 %) 51 (5.11 %) 57 (3.63 %) 60 (4.48 %) 
  Missing  87 (2.99%) 52 (2.72 %) 35 (3.51 %) 44 (2.8 %) 43 (3.21 %) 
  Other  68 (2.34%) 49 (2.56 %) 19 (1.9 %) 43 (2.74 %) 25 (1.87 %) 
Primary insurance, n (%)a      
  Private 1208 (41.5%) 844 (44.1 %) 364 (36.4 %) 719 (45.7 %) 489 (36.5 %) 
  Medicare 1204 (41.3%) 726 (37.9 %) 478 (47.9 %) 565 (35.9 %) 639 (47.7 %) 
  Medicaid 340 (11.68%) 223 (11.66 %) 117 (11.72 %) 177 (11.26 %) 163 (12.17 %) 
  Uninsured 159 (5.46%) 120 (6.27 %) 39 (3.91 %) 111 (7.06 %) 48 (3.58 %) 
Zip (top 3 codes), n (%)      
  32608 34 (1.17%) 22 (1.15 %) 12 (1.2 %) 18 (1.15 %) 16 (1.19 %) 
  32060 27 (0.93%) 16 (0.84 %) 11 (1.1 %) 13 (0.83 %) 14 (1.05 %) 
  32605 27 (0.93%) 21 (1.1 %) 6 (0.6 %) 18 (1.15 %) 9 (0.67 %) 
Socio-economic features      
Neighborhood characteristics      
Rural area, n (%) 767 (26.35%) 503 (26.29 %) 264 (26.45 %) 431 (27.42 %) 336 (25.09 %) 
Total population, median 
(25th-75th) 
19162 
(10639,30611) 
18931 
(10510,30611) 
19363 
(11056,30570) 
18931 
(10448,30459) 
19363 
(11116,30649) 
Median income, median 
(25th-75th) 
34372 
(29980,41410) 
34289 
(29854,41410) 
34476 
(30166,41191) 
34285 
(29689,41363) 
34476 
(30284,41410) 
Total proportion of African-
Americans (%), median 
(25th-75th) 9.64 (3.91,17.6) 9.54 (3.97,16.84) 9.64 (3.80, 18.9) 9.5 (3.91,16.6) 9.64 (3.91,19.5) 
Total proportion of Hispanic 
(%),median (25th-75th) 4.27 (2.54,6.83) 4.28 (2.55,6.73) 4.07 (2.54,7.39) 4.28( 2.65,6.72) 4.19 (2.5,7.15) 
County (top 3 categories), 
n(%)      
  Alachua  383 (13.16%) 261 (13.64 %) 122 (12.22 %)a 221 (14.06 %) 162 (12.1 %) 
  Marion  250 (8.59%) 190 (9.93 %) 60 (6.01 %)a 162 (10.31 %) 88 (6.57 %) 
  Georgia  142 (4.88%) 88 (4.6 %) 54 (5.41 %)a 68 (4.33 %) 74 (5.53 %) 
Distance from residency to 
hospital (km),  
median (25th-75th) 68.0 (28.9,143) 61.7 (28.2,131) 74.0 (30.7,156)a 57.9 (28.2,130) 72.1 (30.7,153)a 
Population proportion below 
poverty (%), median (25th-
75th) 
12.01 
(8.18,17.36) 
12.02  
(8.24,17.41) 
11.81 
(8.04,17.23) 
12.11 
(8.32,17.39) 11.78 (8.04,17.27) 
Preoperative characteristics of patients stratified by acute kidney injury   
Comorbidity features      
Charlson's comorbidity index 
(CCI), median (25th-75th) 2.0 (1.0,3.0) 1.0 (0.0,3.0) 2.0 (1.0,3.0)a 1.0 (0.0,3.0) 2.0 (1.0,3.0)a 
Chronic kidney disease, n (%) 346 (11.89%) 94 (4.91 %) 252 (25.25 %)a 52 (3.31 %) 294 (21.96 %)a 
Operative features      
Admission      
Weekend admission, n (%) 472 (16.21%) 281 (14.69 %) 191 (19.14 %)a 230 (14.63 %) 242 (18.07 %)a 
Admission source, n(%)a      
  Outpatient setting  1753 (60.53%) 1202 (63.3 %) 551 (55.27 %) 1017 (65.15 %) 736 (55.13 %) 
  Emergency room  583 (20.13%) 384 (20.22 %) 199 (19.96 %) 325 (20.82 %) 258 (19.33 %) 
  Transfer  560 (19.34%) 313 (16.48 %) 247 (24.77 %) 219 (14.03 %) 341 (25.54 %) 
Admission month (top 3 
categories), n (%)      
  September  279 (9.58%) 184 (9.62 %) 95 (9.52 %) 149 (9.48 %) 130 (9.71 %) 
  October  273 (9.38%) 195 (10.19 %) 78 (7.82 %) 160 (10.18 %) 113 (8.44 %) 
  June  254 (8.73%) 178 (9.3 %) 76 (7.62 %) 148 (9.41 %) 106 (7.92 %) 
Number of operating 
surgeons, n 129     
Number of procedures per 
operating surgeon, n (%)a      
 First rank  422 (14.5%) 211 (11.03 %) 211 (21.14 %) 162 (10.31 %) 260 (19.42 %) 
 Second rank  267 (9.17%) 207 (10.82 %) 60 (6.01 %) 178 (11.32 %) 89 (6.65 %) 
 Third rank  258 (8.86%) 144 (7.53 %) 114 (11.42 %) 113 (7.19 %) 145 (10.83 %) 
Admitting type, n (%)a      
  surgery  2545 (87.43%) 1725 (90.17 %) 820 (82.16 %) 1437 (91.41 %) 1108 (82.75 %) 
  medicine  366 (12.57%) 188 (9.83 %) 178 (17.84 %) 135 (8.59 %) 231 (17.25 %) 
Emergent surgery, n (%)  1352 (46.44%) 825 (43.13 %) 527 (52.81 %)a 644 (40.97 %) 708 (52.88 %)a 
Surgery type, n (%)a      
  Cardiothoracic surgery  1415 (48.61%) 782 (40.88 %) 633 (63.43 %) 596 (37.91 %) 819 (61.17 %) 
  Other surgeries  826 (28.38%) 569 (29.74 %) 257 (25.75 %) 477 (30.34 %) 349 (26.06 %) 
  Neurologic Surgery  301 (10.34%) 279 (14.58 %) 22 (2.2 %) 243 (15.46 %) 58 (4.33 %) 
  Specialty Surgeries  243 (8.35%) 193 (10.09 %) 50 (5.01 %) 181 (11.51 %) 62 (4.63 %) 
  Non-Cardiac General  126 (4.33%) 90 (4.7 %) 36 (3.61 %) 75 (4.77 %) 51 (3.81 %) 
Time of surgery from 
admission (days) 0.0 (0.0,2.0) 0.0 (0.0,1.0) 1.0 (0.0,4.0)a 0.0 (0.0,1.0) 1.0 (0.0,4.0)a 
Admission day medications      
Diuretics 600 (20.61%) 323 (16.88 %) 277 (27.76 %)a 252 (16.03 %) 348 (25.99 %)a 
Bicarbonate 295 (10.13%) 162 (8.47 %) 133 (13.33 %)a 126 (8.02 %) 169 (12.62 %)a 
Angiotensin-Converting-
Enzyme Inhibitors 351 (12.06%) 205 (10.72 %) 146 (14.63 %)a 163 (10.37 %) 188 (14.04 %)a 
Antiemetic 1413 (48.54%) 1008 (52.69 %) 405 (40.58 %)a 861 (54.77 %) 552 (41.22 %)a 
Betablockers 872 (29.96%) 561 (29.33 %) 311 (31.16 %) 460 (29.26 %) 412 (30.77 %) 
Statin 502 (17.24%) 298 (15.58 %) 204 (20.44 %)a 254 (16.16 %) 248 (18.52 %) 
Pressors or inotropes 424 (14.57%) 228 (11.92 %) 196 (19.64 %)a 173 (11.01 %) 251 (18.75 %)a 
Intraoperative characteristics of patients stratified by acute kidney injury   
Physiologic intraoperative 
time series variables, 
median (25th-75th)      
Diastolic BP - maximum  140 (121,140) 140 (120,140) 140 (125,140)a 140 (119,140) 140 (125,140)a 
Diastolic BP - minimum  20.0 (15.0,25.0) 20.0 (16.0,30.0) 20.0 (13.0,24.0)a 20.0 (16.8,30.0) 20.0 (13.0,25)a 
Diastolic BP - average 58.7 (53.8,65.1) 60.1 (55.2,66.6) 56.5 (51.9,62.1)a 60.9 (55.6,67.2) 56.8 (52.4,62.3)a 
Diastolic BP - long-term 
variability  10.4 (8.7,12.7) 10.3 (8.4,12.7) 10.7 (9.0,12.7)a 10.2 (8.4,12.6) 10.7 (8.9,12.9)a 
Diastolic BP - short-term 
variability  4.8 (3.8,5.9) 4.8 (3.7,5.9) 5.0 (4.0,6.0)a 4.7 (3.6,5.8) 4.9 (4.0,5.95)a 
Systolic BP - maximum  240 (209,240) 240 (205,240) 240 (215,240) 240 (204,240) 240 (215,240)a 
Systolic BP - minimum  40.0 (31.0,50.0) 40.0 (32.0,55.0) 40.0 (29.3,41.0)a 40.0 (33.0,58.0) 40.0 (29.0,42.0)a 
Systolic BP - average 106 (93.8,118) 110 (96.4,120) 100 (90.3,113)a 111 (97.7,121) 101 (90.9,113)a 
Systolic BP - long-term 
variability  19.6 (15.6,24.2) 18.8 (15.1,23.6) 20.7 (16.9,25.0)a 18.7 (15.0,23.3) 20.5 (16.6,24.9)a 
Systolic BP - short-term 
variability 7.7 (6.1,9.5) 7.7 (6.0,9.4) 7.9 (6.4,9.6)a 7.6 (5.8,9.4) 7.9 (6.4,9.55)a 
Mean Arterial BP - maximum  240 (209,240) 240 (205,240) 240 (215,240) 240 (204,240) 240 (215,240)a 
Mean Arterial BP - minimum  40.0 (31.0,50.0) 40.0 (32.0,55.0) 40.0 (29.25,41)a 40.0 (33.0,58.0) 40.0 (29.0,42.0)a 
Mean Arterial BP - average 106 (93.8,118) 110 (96.4,120) 100 (90.3,113)a 111 (97.7,121) 101 (90.9,114)a 
Mean Arterial BP - long-term 
variability 19.6 (15.6,24.2) 18.8 (15.1,23.6) 20.7 (16.9,25.0)a 18.7 (15.0,23.3) 20.5 (16.6,24.9)a 
Mean Arterial BP - short-
term variability 7.7 (6.1,9.5) 7.7 (6.0,9.4) 7.9 (6.4,9.6)a 7.6 (5.8,9.4) 7.9 (6.4,9.55)a 
Heart rate - maximum  146 (125,171) 145 (124,168) 148 (127,175)a 143 (123,166) 148 (129,175)a 
Heart rate - minimum  34.0 (18.0,53.0) 38.0 (21.0,55.0) 26.0 (17.0,48.0)a 40.0 (22.0,55.0) 27.0 (17.0,49.0)a 
Heart rate - average 82.8 (73.8,92.7) 82.1 (73.5,92.0) 84.0 (74.5,93.9)a 81.5 (72.8,91.5) 84.2 (75.1,94.1)a 
Heart rate - long-term 
variability 12.4 (8.6,19.3) 11.6 (8.5,18.1) 14.2 (9.22,21.6)a 11.3 (8.4,17.2) 14.0 (9.3,21.65)a 
Heart rate - short-term 
variability 5.5 (4.2,6.6) 5.4 (4.0,6.5) 5.75 (4.5,6.8)a 5.3 (3.88,6.4) 5.8 (4.5,6.8)a 
MAC - maximum  2.59 (1.71,3.42) 2.56 (1.71,3.42) 3.42 (1.91,3.42)a 2.56 (1.71,3.42) 3.42 (1.94,3.42)a 
MAC - average 0.6 (0.5,0.7) 0.6 (0.5,0.7) 0.6 (0.5,0.7) 0.6 (0.5,0.7) 0.6 (0.5,0.7) 
MAC - long-term variability 0.3 (0.2,0.4) 0.3 (0.2,0.4) 0.3 (0.2,0.5)a 0.3 (0.2,0.4) 0.3 (0.2,0.5)a 
      
Intraoperative laboratory 
results, median (25th-75th)      
Carboxyhemoglobin in 
arterial - maximum 2.2 (1.4,3.0) 2.1 (1.3,2.9) 2.3 (1.5,3.2)a 2.05 (1.3,2.9) 2.3 (1.4,3.1)a 
Carboxyhemoglobin in 
arterial - mean 1.95 (1.3,2.75) 1.86 (1.2,2.7) 2.1 (1.4,2.9)a 1.8 (1.2,2.66) 2.1 (1.38,2.81)a 
Carboxyhemoglobin in 
arterial - minimum 1.6 (1.1,2.55) 1.5 (1.0,2.5) 1.8 (1.2,2.7)a 1.5 (1.0,2.5) 1.8 (1.1,2.6)a 
Bicarbonate in Arterial - 
maximum 23.3 (21.7,25.0) 23.3 (21.7,24.9) 23.3 (21.6,25.2) 23.3 (21.7,24.9) 23.3 (21.6,25.2) 
Bicarbonate in Arterial - 
mean 22.7 (21.2,24.4) 22.7 (21.3,24.4) 22.5 (21.0,24.4) 22.7 (21.3,24.4) 22.7 (21.0,24.4) 
Bicarbonate in Arterial - 
mean 22.0 (20.4,24.1) 22.7 (21.3,24.4) 22.5 (21.0,24.4) 22.7 (21.3,24.4) 22.7 (21.0,24.4) 
Bicarbonate in Arterial - 
variance 0.0 (0.0,0.84) 0.0 (0.0,0.71) 0.0 (0.0,1.34) 0.0 (0.0,0.69) 0.0 (0.0,1.22) 
Hematocrit - maximum 31.5 (28.7,34.9) 31.5 (28.8,34.9) 31.4 (28.5,34.9) 31.7 (28.9,35.1) 31.4 (28.5,34.7)a 
Hematocrit - mean 30.8 (28.0,34.1) 30.9 (28.2,34.2) 30.6 (27.7,34.0)a 30.9 (28.2,34.3) 30.6 (27.8,33.8)a 
Hematocrit -minimum 30.2 (27.1,33.6) 30.4 (27.4,33.7) 29.8 (26.6,33.4)a 30.6 (27.5,33.9) 29.9 (26.7,33.3)a 
Hematocrit - variance 0.0 (0.0,1.12) 0.0 (0.0,0.98) 0.0 (0.0,1.47) 0.0 (0.0,1.12) 0.0 (0.0,1.16) 
Hemoglobin in arterial - 
maximum 11.0 (10.0,12.2) 11.1 (10.1,12.2) 11.0 (9.93,12.2) 11.1 (10.2,12.3) 11.0 (9.9,12.2)a 
Hemoglobin in arterial - 
mean 10.55 (9.6,11.8) 10.62 (9.7,11.85) 10.49 (9.5,11.6)a 10.7 (9.76,11.9) 10.47 (9.5,11.6)a 
Hemoglobin in arterial - 
mimimum 10.2 (9.0,11.6) 10.3 (9.1,11.6) 10.1 (8.7,11.5)a 10.4 (9.2,11.7) 10.1 (8.8,11.4)a 
Hemoglobin in arterial - 
variance 0.0 (0.0,0.44) 0.0 (0.0,0.39) 0.0 (0.0,0.6) 0.0 (0.0,0.36) 0.0 (0.0,0.6) 
Lactic acid - maximum 2.5 (1.5,4.2) 2.1 (1.4,3.4) 3.55 (2.1,5.4)a 2.0 (1.3,3.2) 3.3 (1.9,5.15)a 
Lactic acid - mean 2.2 (1.4,3.57) 1.8 (1.2,2.9) 2.94 (1.88,4.7)a 1.7 (1.2,2.77) 2.8 (1.75,4.43)a 
Lactic acid - minimum 1.6 (1.1,2.9) 1.4 (1.0,2.5) 2.2 (1.3,4.2)a 1.4 (1.0,2.32) 2.1 (1.3,3.7)a 
Lactic acid -variance 0.0 (0.0,0.25) 0.0 (0.0,0.18) 0.0 (0.0,0.5)a 0.0 (0.0,0.16) 0.0 (0.0,0.5)a 
Mean corpuscular 
hemoglobin concentration - 
maximum 34.5 (33.5,35.5) 34.4 (33.5,35.5) 34.5 (33.6,35.5) 34.4 (33.5,35.5) 34.5 (33.5,35.5) 
Mean corpuscular 
hemoglobin concentration - 
mean 34.3 (33.4,35.3) 34.3 (33.35,35.3) 34.4 (33.5,35.3) 34.3 (33.4,35.3) 34.3 (33.5,35.3) 
Mean corpuscular 
hemoglobin concentration - 
minimum 34.1 (33.2,35.1) 34.1 (33.2,35.1) 34.2 (33.3,35.1) 34.1 (33.2,35.1) 34.2 (33.3,35.1) 
Mean corpuscular 
hemoglobin concentration - 
variance 0.0 (0.0,0.08) 0.0 (0.0,0.08) 0.0 (0.0,0.09) 0.0 (0.0,0.08) 0.0 (0.0,0.05)a 
Mean corpuscular 
hemoglobin - maximum 30.6 (29.4,31.8) 30.6 (29.4,31.8) 30.5 (29.4,31.8) 30.6 (29.4,31.8) 30.5 (29.4,31.8) 
Mean corpuscular 
hemoglobin - mean 30.4 (29.3,31.67) 30.5 (29.2,31.7) 30.4 (29.3,31.6) 30.4 (29.3,31.7) 30.4 (29.3,31.6) 
Mean corpuscular 
hemoglobin - minimum 30.3 (29.1,31.5) 30.3 (29.1,31.6) 30.2 (29.2,31.5) 30.3 (29.1,31.5) 30.3 (29.1,31.5) 
Mean corpuscular 
hemoglobin - variance 0.0 (0.0,0.04) 0.0 (0.0,0.04) 0.0 (0.0,0.05) 0.0 (0.0,0.05) 0.0 (0.0,0.04) 
Mean corpuscular volume - 
maximum 88.6 (85.2,92.2) 88.4 (85.1,92.3) 88.7 (85.4,91.98) 88.4 (85.2,92.2) 88.7 (85.3,92.2) 
Mean corpuscular volume - 
mean 88.2 (85.0,91.8) 88.2 (85.0,92.0) 88.3 (85.2,91.4) 88.1 (85.1,91.9) 88.3 (85.0,91.7) 
Mean corpuscular volume - 
minimum 87.9 (84.7,91.4) 87.9 (84.7,91.8) 87.9 (84.8,90.9) 87.9 (84.9,91.6) 88.0 (84.7,91.3) 
Mean corpuscular volume - 
variance 0.0 (0.0,0.18) 0.0 (0.0,0.18) 0.0 (0.0,0.25) 0.0 (0.0,0.2) 0.0 (0.0,0.18) 
Methemoglobin - max 0.8 (0.6,1.0) 0.8 (0.6,0.9) 0.8 (0.6,1.0)a 0.8 (0.6,0.9) 0.8 (0.6,1.0)a 
Methemoglobin - mean 0.7 (0.52,0.9) 0.7 (0.5,0.83) 0.7 (0.55,0.9)a 0.7 (0.5,0.8) 0.7 (0.56,0.9)a 
Methemoglobin - minimum 0.6 (0.4,0.8) 0.6 (0.4,0.8) 0.6 (0.4,0.9)a 0.6 (0.4,0.8) 0.6 (0.4,0.9)a 
Methemoglobin - variance 0.0 (0.0,0.02) 0.0 (0.0,0.02) 0.0 (0.0,0.03) 0.0 (0.0,0.02) 0.0 (0.0,0.03) 
Mean Platelet Volume - 
maximum 8.0 (7.5,8.7) 7.9 (7.4,8.5) 8.2 (7.6,8.9)a 7.9 (7.4,8.5) 8.2 (7.6,8.8)a 
Mean Platelet Volume - 
mean 7.9 (7.4,8.5) 7.8 (7.35,8.4) 8.05 (7.5,8.7)a 7.8 (7.3,8.35) 8.03 (7.5,8.7)a 
Mean Platelet Volume - 
minimum 7.8 (7.3,8.4) 7.7 (7.2,8.3) 7.9 (7.3,8.57)a 7.7 (7.2,8.2) 7.9 (7.4,8.6)a 
Mean Platelet Volume - 
variance 0.0 (0.0,0.03) 0.0 (0.0,0.03) 0.0 (0.0,0.02) 0.0 (0.0,0.04) 0.0 (0.0,0.02) 
O2 Content, Arterial - 
maximum 15.3 (14.0,16.9) 15.3 (14.0,17.0) 15.2 (13.9,16.9) 15.4 (14.1,17.0) 15.2 (13.9,16.9)a 
O2 Content, Arterial - mean 14.7 (13.4,16.3) 14.8 (13.5,16.4) 14.5 (13.2,16.1)a 14.8 (13.5,16.5) 14.5 (13.2,16.1)a 
O2 Content, Arterial - 
minimum 14.2 (12.5,16.0) 14.3 (12.8,16.1) 13.9 (12.2,15.8)a 14.4 (12.9,16.1) 14.0 (12.3,15.8)a 
O2 Content, Arterial - 
variance 0.0 (0.0,0.91) 0.0 (0.0,0.76) 0.0 (0.0,1.23) 0.0 (0.0,0.74) 0.0 (0.0,1.11) 
O2 saturation - max 99.8 (99.0,100) 99.8 (99.0,100) 99.9 (99.0,100) 99.8 (98.9,100) 99.9 (99.0,100)a 
O2 saturation - mean 99.5 (98.4,100) 99.45 (98.4,100) 99.6 (98.4,100) 99.4 (98.3,100) 99.6 (98.5,100)a 
O2 saturation - minimum 99.3 (97.8,100) 99.3 (97.8,100) 99.4 (97.7,100) 99.2 (97.7,100) 99.4 (97.8,100)a 
O2 saturation - variance 0.0 (0.0,0.02) 0.0 (0.0,0.02) 0.0 (0.0,0.01) 0.0 (0.0,0.02) 0.0 (0.0,0.01) 
Partial pressure of carbon 
dioxide - maximum 42.8 (38.4,47.2) 42.8 (38.2,47.0) 43.4 (38.7,47.6)a 42.8 (38.2,46.9) 43.1 (38.7,47.5)a 
Partial pressure of carbon 
dioxide - mean 40.8 (36.9,45.2) 40.8 (36.8,45.2) 40.9 (37.1,45.2) 40.8 (36.7,45.0) 40.8 (37.2,45.4) 
Partial pressure of carbon 
dioxide - minimum 38.9 (34.55,44.6) 38.8 (34.5,44.5) 39.3 (34.7,44.77) 38.8 (34.3,44.4) 39.2 (34.7,44.8) 
Partial pressure of carbon 
dioxide - variance 0.0 (0.0,6.5) 0.0 (0.0,5.89) 0.0 (0.0,7.2) 0.0 (0.0,5.91) 0.0 (0.0,6.87) 
PF-ratio 90.4 (74.9,118) 91.7 (75.4,122) 87.6 (74.4,113)a 91.4 (75.4,122) 89.3 (74.4,115)a 
pH - maximum 7.38 (7.33,7.43) 7.38 (7.34,7.43) 7.38 (7.32,7.43) 7.38 (7.34,7.43) 7.38 (7.33,7.43) 
pH - mean 7.36 (7.32,7.4) 7.36 (7.33,7.41) 7.36 (7.31,7.4)a 7.36 (7.33,7.41) 7.36 (7.32,7.4)a 
pH - minimum 7.34 (7.3,7.39) 7.34 (7.31,7.39) 7.34 (7.29,7.38)a 7.35 (7.31,7.39) 7.34 (7.29,7.38)a 
Platelet count - maximum 180 (133,239) 194 (143,251) 161 (116,207)a 198 (147,254) 165 (118,211)a 
Platelet count - mean 176 (128,229) 189 (139,243) 154 (109,201)a 192 (142,246) 159 (112,207)a 
Platelet count - minimum 171 (121,223) 183 (133,238) 149 (102,194)a 185 (137,242) 155 (106,202)a 
Platelet count - variance 0.0 (0.0,78.1) 0.0 (0.0,74.3) 0.0 (0.0,82.7) 0.0 (0.0,98.0) 0.0 (0.0,60.5)a 
Red blood cells - maximum 3.59 (3.23,3.97) 3.6 (3.25,3.98) 3.58 (3.22,3.96) 3.6 (3.26,3.99) 3.57 (3.21,3.94)a 
Red blood cells - mean 3.5 (3.16,3.87) 3.51 (3.18,3.88) 3.48 (3.11,3.86)a 3.53 (3.19,3.9) 3.46 (3.12,3.85)a 
Red blood cells - minimum 3.42 (3.07,3.83) 3.44 (3.1,3.84) 3.38 (3.0,3.81)a 3.46 (3.12,3.86) 3.38 (3.01,3.8)a 
Red blood cells - variance 0.0 (0.0,0.02) 0.0 (0.0,0.01) 0.0 (0.0,0.02) 0.0 (0.0,0.01) 0.0 (0.0,0.02) 
Red cell distribution width - 
maximum 14.9 (13.9,16.1) 14.6 (13.7,15.8) 15.3 (14.4,16.7)a 14.5 (13.6,15.6) 15.3 (14.4,16.6)a 
Red cell distribution width - 
mean 14.8 (13.8,15.9) 14.6 (13.7,15.7) 15.2 (14.4,16.5)a 14.4 (13.6,15.5) 15.2 (14.3,16.5)a 
Red cell distribution width - 
minimum 14.7 (13.8,15.9) 14.5 (13.6,15.6) 15.1 (14.2,16.3)a 14.3 (13.6,15.3) 15.1 (14.2,16.3)a 
Red cell distribution width - 
variance 0.0 (0.0,0.01) 0.0 (0.0,0.01) 0.0 (0.0,0.02) 0.0 (0.0,0.01) 0.0 (0.0,0.01) 
White blood cells - maximum 13.6 (9.85,18.3) 13.3 (9.9,17.9) 14.05 (9.7,19.1)a 13.2 (9.8,17.7) 13.9 (9.9,19.1)a 
White blood cells - mean 12.9 (9.3,17.5) 12.7 (9.3,17.1) 13.3 (9.12,17.9) 12.4 (9.3,16.8) 13.3 (9.3,18.3)a 
White blood cells - min 12.1 (8.5,16.9) 11.8 (8.6,16.6) 12.6 (8.3,17.5) 11.6 (8.5,16.3) 12.7 (8.4,17.6)a 
White blood cells - variance 0.0 (0.0,0.85) 0.0 (0.0,0.86) 0.0 (0.0,0.85) 0.0 (0.0,1.12) 0.0 (0.0,0.54)a 
Total blood products in ml 318 (0.0,1250) 0.0 (0.0,750) 793 (0.0,2750)a 0.0 (0.0,727) 750 (0.0,2486)a 
Total estimated blood loss in 
ml 150 (150,500) 150 (150,500) 150 (150,388)a 150 (150,500) 150 (150,400)a 
Total fluids in ml 
2300 
(1400,3600) 
2400  
(1500,3600) 
2200 
(1250,3500) 
2400 
(1500,3550) 2200 (1250,3600) 
Total urine output in ml 650 (300,1150) 650 (300,1100) 650 (346,1200) 600 (300,1100) 700 (350,1200)a 
      
Intraoperative medications, 
n (%)      
Diuretic (vs. No) 329 (11.3%) 141 (7.37 %) 188 (18.84 %)a 100 (6.36 %) 229 (17.1 %)a 
Pressors (vs. No) 1942 (66.71%) 1201 (62.8 %) 741 (74.3 %)a 970 (61.7 %) 972 (72.6 %)a 
      
Other variables      
Total surgery time in mins, 
median (25th-75th) 387 (294,483) 366 (275,455) 427 (338,525)a 352 (265,443) 424 (338,52)a 
Night surgery (vs. No), n (%) 394 (13.53%) 238 (12.44 %) 156 (15.63 %)a 167 (10.62 %) 227 (16.95 %)a 
General anesthesia (vs. 
BL/BM), n (%) 2881 (98.97%) 1893 (98.95 %) 988 (99.0 %) 1553 (98.79 %) 1328 (99.18 %) 
 
a p-value < 0.05 compared to no AKI group.  
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